Intercept Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoi…

Biotechnology
US, New York [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Intercept Pharmaceuticals, Inc. (ICPT) to it's peer group.

Peer Group
Loading...
End of ICPT's Analysis
CIK: 1270073 CUSIP: 45845P108 ISIN: US45845P1084 LEI: - UEI: -
Secondary Listings
ICPT has no secondary listings inside our databases.